Setazindol

This classification denotes an anorexiant with the molecular formula C15H16ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 92D9H0A3WN, chemically known as alpha-(4-chlorophenyl)-2-((methylamino)methyl)benzenemethanol, hydrochloride but generally known as setazindol, which bears US NIH Compound Identifier 193099. European Medicines Agency schedules Setazindol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10501MIG. The term SETAZINDOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). SETAZINDOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule setazindol under HS 29221980 and SITC 51461. As of Q4 2014, SETAZINDOL remains the US FDA Preferred Term for this commodity. Setazindol bears US NLM identifiers UMLS ID C2348196 and NCI Concept Code C72846. SMILES: Clc1ccc(C(O)c2c(CNC)cccc2)cc1.